Abstracts – RGCON 2016
Ovary: Oral Abstract: To assess the role of addition of bevacizumab therapy to carboplatin and paclitaxel as frontline treatment of epithelial ovarian cancer
Year: 2016, Volume: 02, Issue: Supplement 1, July
Disclaimer:
This article was originally published by Wolters Kluwer – Medknow and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Wolters Kluwer – Medknow and was migrated to Scientific Scholar after the change of Publisher.